Value20202021202220232024TTMCash from investing activities9.16 M631 K10.99 M832 K4.71 M5.65 MCash from financing activities56.56 M8.19 M80 K485 K6.44 M8.71 MFree cash flow9.77 M13.33 M15.84 M20.68 M14.33 M12.52 M
AIM ImmunoTech Inc
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.